Irving Parra

Puebla, PUE 72570, Mexico

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Correction to: C-terminal Domain of the Heavy Chain of Tetanus Toxin Ameliorate Lipopolysaccharide Induced Hemiparkinsonism in Rats.

Correction to: C-terminal Domain of the Heavy Chain of Tetanus Toxin Ameliorate Lipopolysaccharide Induced Hemiparkinsonism in Rats.

Journal: Neurotoxicity research
Published: July 29, 2026

C-terminal Domain of the Heavy Chain of Tetanus Toxin Ameliorate Lipopolysaccharide Induced Hemiparkinsonism in Rats.

C-terminal Domain of the Heavy Chain of Tetanus Toxin Ameliorate Lipopolysaccharide Induced Hemiparkinsonism in Rats.

Journal: Neurotoxicity research
Published: March 27, 2026

BSS-4, a diosgenin analogue, reduces carrageenan-induced paw inflammation in rat.

BSS-4, a diosgenin analogue, reduces carrageenan-induced paw inflammation in rat.

Journal: Steroids
Published: January 29, 2025

Peroxisome Proliferator-Activated Receptors (PPARs) May Mediate the Neuroactive Effects of Probiotic Metabolites: An In Silico Approach.

Peroxisome Proliferator-Activated Receptors (PPARs) May Mediate the Neuroactive Effects of Probiotic Metabolites: An In Silico Approach.

Journal: International journal of molecular sciences
Published: January 15, 2025

Antidepressant and Neuroprotective Effects of 3-Hydroxy Paroxetine, an Analog of Paroxetine in Rats.

Antidepressant and Neuroprotective Effects of 3-Hydroxy Paroxetine, an Analog of Paroxetine in Rats.

Journal: The international journal of neuropsychopharmacology
Published: September 06, 2022

Chronic Treatment with the Probiotics Lacticaseibacillus rhamnosus GG and Bifidobacterium lactis BB12 Attenuates Motor Impairment, Striatal Microglial Activation, and Dopaminergic Loss in Rats with 6-Hydroxydopamine-induced Hemiparkinsonism.

Chronic Treatment with the Probiotics Lacticaseibacillus rhamnosus GG and Bifidobacterium lactis BB12 Attenuates Motor Impairment, Striatal Microglial Activation, and Dopaminergic Loss in Rats with 6-Hydroxydopamine-induced Hemiparkinsonism.

Journal: Neuroscience
Published: June 30, 2022

Neuroprotective and Immunomodulatory Effects of Probiotics in a Rat Model of Parkinson's Disease.

Neuroprotective and Immunomodulatory Effects of Probiotics in a Rat Model of Parkinson's Disease.

Journal: Neurotoxicity research
Published: May 25, 2022

Differential Effects of LPS and 6-OHDA on Microglia's Morphology in Rats: Implications for Inflammatory Model of Parkinson's Disease.

Differential Effects of LPS and 6-OHDA on Microglia's Morphology in Rats: Implications for Inflammatory Model of Parkinson's Disease.

Journal: Neurotoxicity research
Published: July 08, 2019

Effectiveness of Fragment C Domain of Tetanus Toxin and Pramipexole in an Animal Model of Parkinson's Disease.

Effectiveness of Fragment C Domain of Tetanus Toxin and Pramipexole in an Animal Model of Parkinson's Disease.

Journal: Neurotoxicity research
Published: June 03, 2018
Showing 1-9 of 9

Last Updated: 09/26/2026